REJUVENATION BIO Trademark
Trademark Overview
On Friday, August 23, 2024, a trademark application was filed for REJUVENATION BIO with the United States Patent and Trademark Office. The USPTO has given the REJUVENATION BIO trademark a serial number of 98713312. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Tuesday, November 12, 2024. This trademark is owned by Rejuvenation Technologies Inc.. The REJUVENATION BIO trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:
Nutraceuticals for the treatment of or prevention of diseases and conditions related to short telomeres; Nutraceuticals for the treatment of or prevention of diseases and conditions of aging; Pharmaceutical preparations for the treatment of or prevention of diseases and conditions related to short telomeres; Pharmaceutical preparations for the treatment of or prevention of diseases and conditions of aging
Research and development in the field of biotechnology; Research and development of medicines
General Information
Serial Number | 98713312 |
Word Mark | REJUVENATION BIO |
Filing Date | Friday, August 23, 2024 |
Status | 681 - PUBLICATION/ISSUE REVIEW COMPLETE |
Status Date | Tuesday, November 12, 2024 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | Tuesday, December 3, 2024 |
Trademark Statements
Goods and Services | Nutraceuticals for the treatment of or prevention of diseases and conditions related to short telomeres; Nutraceuticals for the treatment of or prevention of diseases and conditions of aging; Pharmaceutical preparations for the treatment of or prevention of diseases and conditions related to short telomeres; Pharmaceutical preparations for the treatment of or prevention of diseases and conditions of aging |
NOT AVAILABLE | "BIO" |
Goods and Services | Research and development in the field of biotechnology; Research and development of medicines |
Classification Information
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
Class Status Code | 6 - Active |
Class Status Date | Friday, August 23, 2024 |
Primary Code | 005 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Friday, August 23, 2024 |
Primary Code | 042 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
Party Name | Rejuvenation Technologies Inc. |
Party Type | 10 - Original Applicant |
Legal Entity Type | 03 - Corporation |
Address | Mountain View, CA 94043 |
Trademark Events
Event Date | Event Description |
Friday, August 23, 2024 | NEW APPLICATION ENTERED |
Friday, August 23, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Monday, October 28, 2024 | ASSIGNED TO EXAMINER |
Friday, November 1, 2024 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
Friday, November 1, 2024 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
Friday, November 1, 2024 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
Wednesday, November 6, 2024 | EXAMINERS AMENDMENT E-MAILED |
Wednesday, November 6, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Wednesday, November 6, 2024 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
Wednesday, November 6, 2024 | EXAMINERS AMENDMENT -WRITTEN |
Wednesday, November 6, 2024 | EXAMINER'S AMENDMENT ENTERED |